BEBT-503
/ BeBetter Med
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
September 18, 2023
Study of Orally Administered BEBT-503 in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=57 | Completed | Sponsor: BeBetter Med Inc | Recruiting ➔ Completed
Trial completion
August 24, 2022
Study of Orally Administered BEBT-503 in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=58 | Recruiting | Sponsor: BeBetter Med Inc | Not yet recruiting ➔ Recruiting
Enrollment open
May 26, 2022
Study of Orally Administered BEBT-503 in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=58 | Not yet recruiting | Sponsor: BeBetter Med Inc
New P1 trial
1 to 3
Of
3
Go to page
1